Bausch + Lomb Corporation (TSX:BLCO)

Market Cap	7.89B
Revenue (ttm)	6.89B
Net Income (ttm)	-456.11M
Shares Out	n/a
EPS (ttm)	-1.30
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	595
Average Volume	2,547
Open	22.67
Previous Close	22.51
Day's Range	22.30 - 22.67
52-Week Range	18.11 - 29.37
Beta	0.46
RSI	33.50
Earnings Date	Feb 19, 2025

About Bausch + Lomb

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1853
• Employees: 13,300
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: BLCO

Financial Performance

In 2024, Bausch + Lomb's revenue was $4.79 billion, an increase of 15.56% compared to the previous year's $4.15 billion. Losses were -$317.00 million, 21.9% more than in 2023.

Financial numbers in USD